— Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected.
— Total revenue grew 13.4% to $2.91 billion, vs. $2.92 billion expected. The revenue growth was spread across all segments and all geographic regions in Q4.
— Expects 10-12% growth in revenues for the fiscal year 2020 on a reported basis. Adjusted EPS for this period is projected in the range of $1.74 to $1.79 per share.
— BSX shares were up 0.75% immediately following the announcement.
Most Popular
360 DigiTech (NASDAQ: QFIN) Q3 2021 Research Summary
The positive effects of widespread digitalization and e-commerce growth on China’s financial services industry became more pronounced during the pandemic as the movement restrictions drove more retail customers to online
Activision Blizzard (ATVI): Three reasons why this stock deserves to be on your radar
Shares of Activision Blizzard Inc. (NASDAQ: ATVI) were up 1.6% on Thursday. The stock has dropped 14% since the start of the year. The company has been in the news
IPO Alert: Here’s all you need to know about Remitly Global’s upcoming market debut
The emergence of technology-driven financial services is making people think beyond conventional banks when it comes to availing loans and transferring funds. In a move aimed at taking its business
